RLAY

RLAY R&D to Revenue

1702.27%Fiscal year

Period ending:

RLAY FY R&D/Revenue%
RLAY FY R&D/Revenue19979.55%-2140.67%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

RLAY r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Relay Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
1,702.2664%
3,188.6579%
1,291.8578%
17,838.8849%
9,760.6471%
120.8193%
0%
0%

Compare r&d to revenue

All RLAY financial metrics · RLAY stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.